OpenLB
Open Library of Bioscience
Advanced Search

Journal Of The National Comprehensive Cancer Network

Journal Information
Journal Abbr. J Natl Compr Canc Ne
Web of Sciences Category
Oncology
Print ISSN 1540-1405
E-ISSN 1540-1413
NLM Catelog ID 101162515
Scopus Source ID 146215
Country UNITED STATES
Language English
Publisher Harborside Press
Publisher Address 94 North Woodhull Rd, Huntington, Usa, Ny, 11743

Related Publications

Found 3,303 results

QIM25-234: Models and Outcomes of Multidisciplinary Clinics in Lung Cancer.
Seohyuk Lee, Miguel M Leiva Juarez, Stuart M Berman, Mujtaba Mubashir, Brian M Russell, Deepa Rangachari, Jessica A Zerillo
J Natl Compr Canc Netw. Mar 28, 2025.23(3.5): Electronic
Source:PubMed
PMID: 40159100 doi:10.6004/jnccn.2024.7257
BPI25-015: Implementing a No-Cost Strategy to Minimize Blood Product Waste in a High-Volume Hematology/Oncology Intermediate Care Unit.
Bindu Kuriacose, Annie Abraham, Neicole James
J Natl Compr Canc Netw. Mar 28, 2025.23(3.5): Electronic
Source:PubMed
PMID: 40159136 doi:10.6004/jnccn.2024.7171
EPR25-131: Hematologic Adverse Effects Profile of Immune Checkpoint Inhibitors: A Real-World Pharmacovigilance Study Using FAERS Database.
Syed Maaz Tariq, Shafaq Jawed
J Natl Compr Canc Netw. Mar 28, 2025.23(3.5): Electronic
Source:PubMed
PMID: 40159149 doi:10.6004/jnccn.2024.7274
CLO25-053: Real-World Evidence of Survival in Patients With Metastatic NSCLC Treated With First-Line Immune Checkpoint Inhibitors Beyond Progression.
Natalie Johns, Alexander Rudich, Songzhu Zhao, Kenneth Chian, Po-Lan Su, Adam Khorasanchi, Jinesh Gheeya, Daniel Spakowicz, Lai Wei, Logan Roof, Asrar Alahmadi, Regan Memmott, Jacob Kaufman, Carolyn Presley, Kai He, Peter Shields, Christian Rolfo, David Carbone, Dwight Owen, Mingjia Li
J Natl Compr Canc Netw. Mar 28, 2025.23(3.5): Electronic
Source:PubMed
PMID: 40159135 doi:10.6004/jnccn.2024.7160
CLO25-063: Immune Checkpoint Inhibitor Therapy and the Risk of Second Primary Malignancies in Melanoma and Lung Cancer Patients.
Muntaser Al Zyoud, Osama M Younis, Muhammad Awidi
J Natl Compr Canc Netw. Mar 28, 2025.23(3.5): Electronic
Source:PubMed
PMID: 40159151 doi:10.6004/jnccn.2024.7144
CLO25-098: Impact of Bone Metastasis on Survival in Gastric and Gastroesophageal Junction Tumors.
Muhammad Awidi, Muntaser Al Zyoud, Osama M Younis, Sarbajit Mukherjee
J Natl Compr Canc Netw. Mar 28, 2025.23(3.5): Electronic
Source:PubMed
PMID: 40159140 doi:10.6004/jnccn.2024.7116
PCO25-210: Design of Novel Antibody Drug Conjugates Using a Fully Humanized Monoclonal Antibody Targeting the Human Neuronal Pentraxin Receptor (YB800-ADCs) for Therapeutic Intervention in Oncology.
Peter Schiemann, Michel Janicot, Gunther Wennemuth, Mykola Lyndin, Janine Moyer
J Natl Compr Canc Netw. Mar 28, 2025.23(3.5): Electronic
Source:PubMed
PMID: 40159131 doi:10.6004/jnccn.2024.7276
HSR25-186: A Systematic Review and Meta-Analysis of Randomized Controlled Trials to Evaluate the Risk of General Systemic Adverse Events in Locally Advanced Head and Neck Squamous Cell Carcinoma Treated With Immune Checkpoint Inhibitors.
Taimur Khalid, Hazem Aboaid, Daniel Thomas Jones, Jason Ta, Ramaditya Srinivasmurthy, Kenny Do, Kevin Nguyen, Karina Fama, Rishi Kumar Nanda, Sarah Aamer, Jo-Lawrence Bigcas, Kyaw Zin Thein
J Natl Compr Canc Netw. Mar 28, 2025.23(3.5): Electronic
Source:PubMed
PMID: 40159142 doi:10.6004/jnccn.2024.7329
HSR25-142: Assessment of Community Oncology Palliative and Supportive Care Program in Improving Patient's Quality of Life: A Patients Perspective.
MaryAnn Fragola
J Natl Compr Canc Netw. Mar 28, 2025.23(3.5): Electronic
Source:PubMed
PMID: 40159150 doi:10.6004/jnccn.2024.7295
CLO25-074: Outcomes to Immune Checkpoint Inhibitors (ICIs) According to Programmed Death-Ligand 1 (PD-L1) Levels in KRAS-, KEAP1-, STK11-Mutant Lung Squamous Cell Carcinoma (LSCC).
Justin W Shi, Ahmad Karkash, Weston He, Mya T Tran, Yan Han, Misty Dawn Shields, Julian A Marin-Acevedo
J Natl Compr Canc Netw. Mar 28, 2025.23(3.5): Electronic
Source:PubMed
PMID: 40159148 doi:10.6004/jnccn.2024.7142